NetraMark Holdings Inc C.AIAI

Alternate Symbol(s): AINMF

Healthcare Medical Devices

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.

CSE:AIAI - Post by User

NetraMark Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by StockHawk1on Nov 01, 2021 7:01pm

57 Views

Post# 34075244

DD for MEND

The global mental health apps market is expected to reach $310 B by 2027. Having both a personal and investment-focused interest in AI and mental health. I just discovered a company that I'm feeling really excited about.

Nurosene Health ( $MEND.C $MNNDF ) is a mental wellness tech company. Currently, they are leveraging technological advancements in AI to create a wellness app that will help to track and improve customers' mental health.

Physical and mental health is so strongly related. $MEND's app uses physical health data to determine wellness patterns and extract actionable insights for complex patient populations.